Jazz Pharmaceuticals plc (JAZZ)
FlaggedUS listed · Healthcare · Biotechnology
This page tracks Jazz Pharmaceuticals plc (JAZZ) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews JAZZ against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Sep 21, 2026Screen strength 3.8The pre-screen's STRONG_BUY signal is only partially confirmed. Supporting factors include a solid 1.16 Sharpe ratio, exceptional 49.75% 1Y CAGR, price above both rising moving averages (SMA-50 $248.99, SMA-200 $208.83), and a defensive 0.37 beta insulating against broad-market fear. Recent news is bullish (oncology pipeline expansion, $820M Actio acquisition to strengthen epilepsy franchise, $3B–$5B opportunity outlined). However, critical contradictions weaken conviction: today's volume collapse to 0.04x average (41,091 shares vs 1.075M typical) signals a complete lack of participation on what should be a bullish setup; the MACD is negative with a falling histogram and no crossover; RSI is neutral (47.43) with no directional thrust; and the stock has been churning sideways in a tight $240–$248 range since early September despite the positive news flow. The pre-screen score of 3.84/10 is itself marginal (the borderline of moderate conviction). This is a genuine long-side lean with fundamental and macro tailwinds, but the technical setup lacks conviction and today's near-zero volume is a red flag for execution risk.
JAZZ AI Signal Track Record
Recent scanner signals for Jazz Pharmaceuticals plc. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Screen strength | Price at signal |
|---|---|---|---|
| Sep 21, 2026 | Flagged | 3.8 | $243.80 |
| Sep 21, 2026 | Flagged | 3.8 | $243.65 |
| Sep 21, 2026 | Flagged | 3.8 | $244.13 |
| Sep 21, 2026 | Flagged | 3.8 | $244.12 |
JAZZ — Frequently Asked Questions
Is Jazz Pharmaceuticals plc (JAZZ) a buy right now?
As of September 21, 2026, StockTracker AI's screen flags JAZZ as Flagged, with a ±1.7% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is JAZZ's RSI?
JAZZ's 14-day RSI was 47.4 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for JAZZ?
StockTracker AI generates a probability-weighted 30-day price forecast for JAZZ — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze JAZZ?
Each scan screens JAZZ on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for JAZZ — free.
Add JAZZ to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for JAZZ
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →